Rev Invest Clin
-
Meta Analysis
Immunomodulation as a treatment for parkinson's disease in current trials: a systematic review and meta-analysis.
Immunomodulatory drugs and immunotherapies are being evaluated in clinical trials for the treatment of neuroinflammation, as the latter is an essential mechanism for the development and progression of Parkinson's disease. ⋯ The immunomodulatory treatments included in this study showed no efficacy in improving motor symptoms in Parkinson's disease patients. Further clinical trials with larger patient populations are needed.